news banner
 

children's news

other publications

news room

giving

 
 

Insurance status may affect children’s mortality after trauma

The federal Emergency Medical Treatment and Active Labor Act requires hospitals to treat trauma patients until they’re medically stable, regardless of insurance status. Yet a retrospective study led by Heather Rosen, MD, MPH, research fellow in Children’s Hospital Boston’s Department of Plastic Surgery, found that uninsured children were 3.3 times more likely to die from trauma-related injuries than children with commercial insurance plans like Blue Cross/Blue Shield. In addition, children insured by public plans like Medicaid or SCHIP were 1.19 times more likely to die from trauma than commercially insured children.

The study, published in the Journal of Pediatric Surgery in October, analyzed data from the National Trauma Data Bank and adjusted for factors such as age, gender, race, injury severity and injury type. Because the study was retrospective, the researchers aren’t sure why the mortality rates differed. They speculate that trauma patients with public or no insurance get fewer diagnostic tests, or are transferred from one hospital to another, delaying proper treatment. Or their families may be less educated or less fluent in English and therefore less able to communicate effectively with medical providers.

“This paper provokes more questions than it answers,” Rosen acknowledges. In the future, she would like to conduct a prospective study, looking at differences in quality of care in real time. Rosen also published a parallel study of 687,000 adults admitted for trauma in the November Archives of Surgery. Similar to the pediatric study, uninsured patients had 1.8 times greater mortality than insured patients.

 
 
 

Stimulus grant to fund a "Manhattan project" on autism

Probing life-treatening flu

Regrowing damaged hearts

Trimming fat boosts blood recovery after bone marrow transplant

A drug-dispensing contact lens

A urine test for appendicitis?

A new lead for autoimmune disease

Building better anesthetics and anti-inflammatory drugs

 

 

   

Subscribe to our RSS feed

 

 

Email this page to a friend

 

  Contact Us